BELLUOMINI, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 38
EU - Europa 22
AS - Asia 10
Totale 70
Nazione #
US - Stati Uniti d'America 38
FR - Francia 10
IT - Italia 6
DE - Germania 3
IN - India 2
MY - Malesia 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
CN - Cina 1
FI - Finlandia 1
OM - Oman 1
PH - Filippine 1
SG - Singapore 1
TW - Taiwan 1
Totale 70
Città #
Santa Cruz 6
Ashburn 3
Agna 2
Bologna 2
Bremen 2
Columbus 2
Des Moines 2
Hyderabad 2
Kuala Lumpur 2
Stockholm 2
Baguio City 1
Brookline 1
Buffalo 1
Crugers 1
Dallas 1
Fairfield 1
Ferrara 1
Helsinki 1
Houston 1
Los Angeles 1
Miami 1
Muscat 1
Nîmes 1
Paris 1
San Jose 1
Shanghai 1
Tainan City 1
Woodbridge 1
Totale 43
Nome #
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke, file e309ade3-dbbb-3969-e053-3a05fe0a2c94 44
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC, file e309ade3-ccb5-3969-e053-3a05fe0a2c94 8
Estrogen receptor mutation: a new strategy to overcome endocrine resistance, file 8f1c9a9a-391d-441b-b9b3-8c9803bb2d76 7
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC, file d6a71a76-1258-4a30-b8f0-e68ae26031a9 3
Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities?, file e309ade2-9dcb-3969-e053-3a05fe0a2c94 3
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study, file fcc6b5b4-66e0-4986-a495-cb149c294954 3
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: Implications for personalised treatment, file e309ade1-87d4-3969-e053-3a05fe0a2c94 2
Totale 70
Categoria #
all - tutte 599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 1 0 0 0
2021/202215 0 0 0 0 0 0 4 0 2 0 6 3
2022/202330 0 0 11 8 3 2 2 2 0 2 0 0
2023/202424 0 3 0 2 1 3 0 3 5 4 3 0
Totale 70